prof. Eva Van Braeckel
- ORCID iD
-
0000-0002-7242-0747
Show
Sort by
-
Cystic fibrosis as a modulable model for CFTR-related Immune dysregulation
-
- Journal Article
- A1
- open access
Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103) : results from two randomised, active-controlled, phase 3 trials
-
Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis
-
- Journal Article
- A1
- open access
Use of inhaled corticosteroids in bronchiectasis : data from the European Bronchiectasis Registry (EMBARC)
-
- Journal Article
- A1
- open access
Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant Aspergillus fumigatus
-
Replication stress, microcephalic primordial dwarfism, and compromised immunity in ATRIP deficient patients
-
- Journal Article
- A1
- open access
Healthcare worker views on antimicrobial resistance in chronic respiratory disease
-
Rectal organoid morphology analysis (ROMA) as a novel physiological assay for diagnostic classification in cystic fibrosis
-
Cystic fibrosis and the role of CFTR in circulating immune cells : a human single-cell atlas
-
Modulation is not an independent determinant of the viscoelastic properties of sputum in cystic fibrosis